Pharmanutra SpA

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Sep'25 - YoY",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in quarter ended Sep 2025 is 19.34% vs 25.69% in Sep 2024",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in quarter ended Sep 2025 is 11.63% vs 72.00% in Sep 2024",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Sep'25",
        "Sep'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "32.70",
          "val2": "27.40",
          "chgp": "19.34%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "8.70",
          "val2": "7.50",
          "chgp": "16.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.40",
          "val2": "0.30",
          "chgp": "33.33%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "-0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "4.80",
          "val2": "4.30",
          "chgp": "11.63%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "240.90%",
          "val2": "244.80%",
          "chgp": "-0.39%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2024 is 15.27% vs 21.16% in Dec 2023",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2024 is 29.69% vs -14.67% in Dec 2023",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "115.50",
          "val2": "100.20",
          "chgp": "15.27%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "30.20",
          "val2": "24.90",
          "chgp": "21.29%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "1.70",
          "val2": "1.20",
          "chgp": "41.67%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.30",
          "val2": "0.40",
          "chgp": "-25.00%",
          "chgp_class": "negative"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "16.60",
          "val2": "12.80",
          "chgp": "29.69%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "232.90%",
          "val2": "223.90%",
          "chgp": "0.90%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Sep'25 - YoY

Sep'25

Sep'24

Change(%)

Net Sales

32.70

27.40

19.34%

Operating Profit (PBDIT) excl Other Income

8.70

7.50

16.00%

Interest

0.40

0.30

33.33%

Exceptional Items

-0.00

0.00

Consolidate Net Profit

4.80

4.30

11.63%

Operating Profit Margin (Excl OI)

240.90%

244.80%

-0.39%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in quarter ended Sep 2025 is 19.34% vs 25.69% in Sep 2024

Consolidated Net Profit

YoY Growth in quarter ended Sep 2025 is 11.63% vs 72.00% in Sep 2024

All Quarterly Results

Annual Results Snapshot (Consolidated) - Dec'24

Dec'24

Dec'23

Change(%)

Net Sales

115.50

100.20

15.27%

Operating Profit (PBDIT) excl Other Income

30.20

24.90

21.29%

Interest

1.70

1.20

41.67%

Exceptional Items

0.30

0.40

-25.00%

Consolidate Net Profit

16.60

12.80

29.69%

Operating Profit Margin (Excl OI)

232.90%

223.90%

0.90%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in year ended Dec 2024 is 15.27% vs 21.16% in Dec 2023

Consolidated Net Profit

YoY Growth in year ended Dec 2024 is 29.69% vs -14.67% in Dec 2023

All Annual Results